Alkyl Amines Chemicals (506767) Q4 25/26 earnings summary

Executive summary

• FY 2026 saw flat top-line and bottom-line performance, with revenue and profit within ±1% of last year, reflecting challenging market conditions and limited growth.

• Audited financial results for the quarter and year ended March 31, 2026, were approved with an unmodified audit opinion from the statutory auditor.

• Market share was retained or slightly increased across key markets despite operational disruptions in March due to ammonia supply issues linked to geopolitical events.

• A final dividend of Rs. 10 per equity share (500%) for FY 2025-26 was recommended, subject to shareholder approval.

• Management expressed cautious optimism for the coming year, expecting improvement over the last three years' subdued performance.

Financial highlights

• Revenue from operations for FY 2025-26 was Rs. 1,535.85 crore, compared to Rs. 1,571.82 crore in FY 2024-25.

• Net profit after tax for FY 2025-26 was Rs. 180.00 crore, down from Rs. 186.11 crore in FY 2024-25.

• Volume and value both declined by about 1%, resulting in a combined 2% drop year-over-year.

• Margins temporarily improved in March due to inventory of lower-cost raw materials, but this is not expected to sustain.

• Current selling prices for key products: methylamines INR 100–110/kg, ethylamines INR 200+/kg, acetonitrile INR 200+/kg, with acetonitrile up 30–40% from last year.

Outlook and guidance

• Volume growth of 5–10% is expected for the next year, in line with industry trends.

• Margins are anticipated to improve modestly, but not return to pre-February levels soon due to persistent high raw material costs.

• Top-line growth will be driven by elevated prices, but volume growth will remain moderate.

• The company continues to monitor regulatory changes, especially regarding new labour codes, and will adjust accounting as needed.